Entering a new era of rational biomarker discovery for early detection of melanoma metastases: Secretome analysis of associated stroma cells

Journal of Proteome Research

Volumn 8, Issue 5, 2009, Pages 2501-2510

  Paulitschke, Verena ^a   Kunstfeld, Rainer ^a   Mohr, Thomas ^b   Slany, Astrid ^b   Micksche, Michael ^b   Drach, Johannes ^b   Zielinski, Christoph ^b   Pehamberger, Hubert ^a   Gerner, Christopher ^b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Author; Keywords; Please; Provide

Indexed keywords

HYPOCALCIN; PROTEIN GPX5; TRANSCRIPTION FACTOR RUNX2; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; METASTASIS; MOUSE; MULTIPLE MYELOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEOMICS; SKIN FIBROBLAST; STROMA CELL;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEASIBILITY STUDIES; FEMALE; FIBROBLASTS; HUMANS; MASS SPECTROMETRY; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, SCID; NEOPLASM METASTASIS; PROTEOME; PROTEOMICS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 66749092374     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8010827     Document Type: Article

References (43)

1. Miller, A. J.; Mihm, M. C., Jr. Melanoma. N. Engl. J. Med . 2006, 355 (1), 51-65.
2. Omholt, K.; Platz, A.; Kanter, L.; Ringborg, U.; Hansson, J. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin. Cancer Res . 2003, 9 (17), 6483-8.
3. Hsu, M. Y.; Wheelock, M. J.; Johnson, K. R.; Herlyn, M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Investie. Dermatol. Symp. Proc . 1996, 1 (2), 188-94.
4. Danen, E. H.; Ten Berge, P. J.; Van Muijen, G. N.; Van 't Hof-Grootenboer, A. E.; Brocker, E. B.; Ruiter, D. J. Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histovatholoev 1994, 24 (3), 249-56.
5. Tsao, H.; Sober, A. J. Melanoma treatment update. Dermatol. Clin . 2005, 23 (2), 323-33.
6. Weidner, N.; Folkman, J. Tumoral vascularity as a prognostic factor in cancer. Important Adv. Oncol . 1996, 167-90.
7. Dadras, S. S.; Paul, T.; Bertoncini, J.; Brown, L. F.; Muzikansky, A.; Jackson, D. G.; Ellwanger, U.; Garbe, C.; Mihm, M. C.; Detmar, M. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am. J. Pathol . 2003, 162 (6), 1951-60.
8. Schamberger, C. J.; Gerner, C.; Cerni, C. bFGF rescues 423-cells from serum starvation-induced apoptosis downstream of activated caspase-3. FEBS Lett . 2004, 573 (1-3), 19-25.
9. Mantovani, A.; Allavena, P.; Sica, A. Tumour-associated macroph- ages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur. J. Cancer 2004, 40 (11), 1660-7.
10. Culp, W. D.; Neal, R.; Massey, R.; Egevad, L.; Pisa, P.; Garland, D. Proteomic analysis of tumor establishment and growth in the B16- F10 mouse melanoma model. J. Proteome Res . 2006, 5 (6), 1332-43.
11. Liotta, L. A.; Kohn, E. C. The microenvironment of the tumour- host interface. Nature 2001, 411 (6835), 375-9.
12. Jungbluth, A. A. Serological reagents for the immunohistochemical analysis of melanoma metastases in sentinel lymph nodes. Semin. Diaen. Pathol . 2008, 25 (2), 120-5.
13. Ohsie, S. J.; Sarantopoulos, G. P.; Cochran, A. J.; Binder, S. W. Immunohistochemical characteristics of melanoma. J. Cutan. Pathol . 2008, 35 (5), 433-44.
14. Sekulic, A.; Haluska, P., Jr.; Miller, A. J.; Genebriera De Lamo, J.; Ejadi, S.; Pulido, J. S.; Salomao, D. R.; Thorland, E. C.; Vile, R. G.; Swanson, D. L.; Pockaj, B. A.; Laman, S. D.; Pittelkow, M. R.; Markovic, S. N. Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin. Proc . 2008, 83 (7), 825-46.
15. Mischak, H.; Apweiler, R.; Banks, R. E.; Conaway, M.; Coon, J.; Dominiczak, A.; Ehrich, J. H. H.; Fliser, D.; Girolami, M.; Herm- jakob, H.; Hochstrasser, D.; Jankowski, J.; Julian, B. A.; Kolch, W.; Massy, Z. A.; Neusuess, C.; Novak, J.; Peter, K.; Rossing, K.; Schanstra, J.; Semmes, O. J.; Theodorescu, D.; Thongboonkerd, V.; Weissinger, E. M.; Van Eyk, J. E.; T., Y. Clinical proteomics: Aneed to define the field and to begin to set adequate standards. Proteomics: Clin. Appl . 2007, 1 (2), 148-156.
16. Tjalsma, H.; Bolhuis, A.; Jongbloed, J. D.; Bron, S.; van Dijl, J. M. Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol. Mol. Biol. Rev . 2000, 64 (3), 515-47.
17. Greenbaum, D.; Luscombe, N. M.; Jansen, R.; Qian, J.; Gerstein, M. Interrelating different types of genomic data, from proteome to secretome: 'oming in on function. Genome Res . 2001, 11 (9), 1463-8.
18. Hagendoorn, J.; Tong, R.; Fukumura, D.; Lin, Q.; Lobo, J.; Padera, T. P.; Xu, L.; Kucherlapati, R.; Jain, R. K. Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res . 2006, 66 (7), 3360-4.
19. Petricoin, E. F.; Belluco, C.; Araujo, R. P.; Liotta, L. A. The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat. Rev. Cancer 2006, 6 (12), 961-7.
20. Zwickl, H.; Traxler, E.; Staettner, S.; Parzefall, W.; Grasl-Kraupp, B.; Karner, J.; Schulte-Hermann, R.; Gerner, C. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 2005, 26 (14), 2779-85.
21. Kunstfeld, R.; Wickenhauser, G.; Michaelis, U.; Teifel, M.; Umek, W.; Naujoks, K.; Wolff, K.; Petzelbauer, P. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J. Invest. Dermatol . 2003, 120 (3), 476-82.
22. Frazier, M. L.; Pathak, S.; Wang, Z. W.; Cleary, K.; Singletary, S. E.; Olive, M.; Mackay, B.; Steck, P. A.; Levin, B. Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3. Pancreas 1990, 5 (1), 8-16.
23. Pickl, W. F.; Majdic, O.; Kohl, P.; Stockl, J.; Riedl, E.; Scheinecker, C.; Bello-Fernandez, C.; Knapp, W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol . 1996, 157 (9), 3850-9.
24. Jaffe, E. A.; Nachman, R. L.; Becker, C. G.; Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest . 1973, 52 (11), 2745-56.
25. Jones, P.; Cote, R. G.; Cho, S. Y.; Klie, S.; Martens, L.; Quinn, A. F.; Thorneycroft, D.; Hermjakob, H. PRIDE: new developments and new datasets. Nucleic Acids Res . 2008, 36 (Database issue), D878-83.
26. Jones, P.; Cote, R. G.; Martens, L.; Quinn, A. F.; Taylor, C. F.; Derache, W.; Hermjakob, H.; Apweiler, R. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res . 2006, 34 (Database issue), D659-63.
27. Gundacker, N.; Bayer, E.; Traxler, E.; Zwickl, H.; Kubicek, M.; Stockl, J.; Gerner, C. Knowledge-based proteome profiling: considering identified proteins to evaluate separation efficiency by 2-D PAGE. Electrophoresis 2006, 27 (13), 2712-21.
28. Slany, A.; Haudek, V. J.; Gundacker, N., C.; Griss, J.; Mohr, T.; Wimmer, H.; Eisenbauer, M.; Elbling, L.; Gerner, C. Introducing a New Parameter for Quality Control of Proteome Profiles: Consideration of Commonly Expressed Proteins. Electrophoresis 2008, (in press).
29. Okamoto, O.; Fujiwara, S. Dermatopontin, a novel player in the biology of the extracellular matrix. Connect Tissue Res . 2006, 47 (4), 177-89.
30. Klagsbrun, M.; Takashima, S.; Mamluk, R. The role of neuropilin in vascular and tumor biology. Adv. Exp. Med. Biol . 2002, 515 , 33-48.
31. Shi-Wen, X.; Leask, A.; Abraham, D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev . 2008, 19 (2), 133-44.
32. Fukushima, T.; Kataoka, H. Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma. Anticancer Res . 2007, 27 (6A), 3685-92.
33. Rajah, R.; Katz, L.; Nunn, S.; Solberg, P.; Beers, T.; Cohen, P. Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. Prog. Growth Factor Res . 1995, 6 (2 -4), 273-84.
34. Himelstein, B. P.; Canete-Soler, R.; Bernhard, E. J.; Dilks, D. W.; Muschel, R. J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994, 14 (1-6), 246-58.
35. Ludwig, J. A.; Weinstein, J. N. Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 2005, 5 (11), 845-56.
36. Hall, L.; Williams, K.; Perry, A. C.; Frayne, J.; Jury, J. A. The majority of human glutathione peroxidase type 5 (GPX5) transcripts are incorrectly spliced: implications for the role of GPX5 in the male reproductive tract. Biochem. J . 1998, 333 (Pt 1), 5-9.
37. The universal protein resource (UniProt). Nucleic Acids Res . 2008, 36 (Database issue), D190-5.
38. Wittgen, H. G.; van Kempen, L. C. Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Res . 2007, 17 (6), 400-9.
39. Tohmiya, Y.; Koide, Y.; Fujimaki, S.; Harigae, H.; Funato, T.; Kaku, M.; Ishii, T.; Munakata, Y.; Kameoka, J.; Sasaki, T. Stanniocalcin-1 as a novel marker to detect minimal residual disease of human leukemia. Tohoku J. Exp. Med . 2004, 204 (2), 125-33.
40. Joensuu, K.; Heikkila, P.; Andersson, L. C. Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer. Cancer Lett . 2008, 265 (1), 76-83.
41. Kikuchi, Y.; Kashima, T. G.; Nishiyama, T.; Shimazu, K.; Morishita, Y.; Shimazaki, M.; Kii, I.; Horie, H.; Nagai, H.; Kudo, A.; Fukayama, M. Periostin is expressed in pericryptal fibroblasts and cancer- associated fibroblasts in the colon. J. Histochem. Cytochem . 2008, 56 (8), 753-64.
42. Kanno, A.; Satoh, K.; Masamune, A.; Hirota, M.; Kimura, K.; Umino, J.; Hamada, S.; Satoh, A.; Egawa, S.; Motoi, F.; Unno, M.; Shimo- segawa, T. Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchy- mal transition of human pancreatic cancer cells. Int. J. Cancer 2008, 122 (12), 2707-18.
43. Tilman, G.; Mattiussi, M.; Brasseur, F.; van Baren, N.; Decottignies, A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol. Cancer 2007, 6 , 80.